The efficacy and safety of low intensity warfarin therapy in Chinese elderly atrial fibrillation patients with high CHADS2 risk score

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 3067-3068

  Wu, Jun ^a   Wang, Junhong ^a   Jiang, Surong ^a   Xu, Jian ^a   Di, Qun ^a   Zhou, Chuanwei ^a   Min, Xiaoyan ^a   Pang, Sisi ^a   Wang, Hui ^a,b   Xu, Di ^a   Guo, Yan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Department of Cardiology   (China)

Author keywords

Anticoagulation; Atrial fibrillation; Elderly; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AGED; ANTICOAGULANT THERAPY; BLEEDING; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CHINESE; DEEP VEIN THROMBOSIS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTICOAGULATION; ATRIAL FIBRILLATION; ELDERLY; WARFARIN;

AGED, 80 AND OVER; ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WARFARIN;

EID: 84883754030     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.11.078     Document Type: Article

References (6)

1. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 1991 983 988
2. T.J. Bungard, W.A. Ghali, and K.K. Teo Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46
3. L.S. Wann, A.B. Curtis, and C.T. January 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 104 123
4. J. Mant, F.D. Hobbs, and K. Fletcher Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
5. The ACTIVE Writing Group on behalf of the ACTIVE Investigators Clopidogrel plus aspirin versus oral anticoagulation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
6. F. Catella-Lawson, M.P. Reilly, and S.C. Kapoor Cyclooxygenase inhibitors and the antiplatelet effect of aspirin N Engl J Med 345 2001 1809 1817